Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Outset Medical, Inc. OM

Set alert

Price alert · OM

All alert types
4.12 USD +0.10 +2.36%

As of Nov 3, 10:58 AM ET

Bid
4.02 × 2
Ask
4.13 × 1
3.95 Day range 4.12
2.84 52-week range 12.97
YTD
+10.92%
1 year
-68.37%
Open
3.95
Prev close
4.02
Mkt cap
77.35M
Vol
7.83K
Avg vol
152.01K
EPS
-4.00
P/E
0.00
Div yield
0.00%
More statistics
Low
3.95
High
4.12
Forward P/E
-0.89
Beta
1.95
Short ratio
2.94
Inst. own
52.16%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
0.82834
200-d avg
2.07
1y target
4.00

6M chart

Chart tools
Interval
1m5m15m30m

Signals (49)
NameDateAgo
MACD: Sell SignalNov 2, 20261 day ago
SMA: BearishOct 30, 20264 days ago
SMA: BullishOct 27, 20261 week ago
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 20, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BearishOct 14, 20262 weeks ago
SMA: BearishOct 8, 20263 weeks ago
SMA: BullishOct 7, 20263 weeks ago
SMA: BullishOct 2, 20261 month ago
RSI: OversoldSep 28, 20261 month ago
MACD: Buy SignalSep 22, 20261 month ago
RSI: OversoldSep 9, 20261 month ago
SMA: BearishAug 18, 20262 months ago
SMA: BullishAug 14, 20262 months ago
SMA: BearishAug 13, 20262 months ago
MACD: Sell SignalAug 13, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BullishJul 28, 20263 months ago
MACD: Buy SignalJul 28, 20263 months ago

Newest 20 of 49.

Analyst view

Consensus: buy

Buy
Price target (mean) 4.00 -2.8% downside
Target (low)
3.00
Target (mean)
4.00
Target (high)
6.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy3
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 6
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

OM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.405-0.42 – -0.37-0.59+31.4%27.85M-8.7%4
Next quarter-0.36333-0.39 – -0.34-0.57+36.3%29.58M+5.0%3
Current year-1.85-1.87 – -1.80-2.70+31.5%112.08M-13.8%4
Next year-1.34-1.45 – -1.25-1.85+27.8%125.26M+11.8%4

Upgrades and downgrades

The latest rating changes

OM analyst upgrades and downgrades
DateFirmActionFromTo
Aug 8, 2024RBC CapitalDowngradeOutperformSector Perform
Aug 8, 2024TD CowenMaintainedBuyBuy
Jun 21, 2024RBC CapitalUpgradeSector PerformOutperform
Apr 8, 2024BTIGInitiated—Buy
Jan 12, 2024RBC CapitalDowngradeOutperformSector Perform
Dec 4, 2023Morgan StanleyMaintainedEqual-WeightEqual-Weight
Nov 14, 2023Morgan StanleyMaintainedEqual-WeightEqual-Weight
Oct 13, 2023RBC CapitalMaintainedOutperformOutperform
Oct 13, 2023StifelMaintainedBuyBuy
Oct 13, 2023B of A SecuritiesDowngradeBuyUnderperform
Aug 24, 2023Morgan StanleyMaintainedEqual-WeightEqual-Weight
Aug 17, 2023RBC CapitalReiteratedOutperformOutperform
Aug 17, 2023CL KingInitiated—Neutral
Aug 3, 2023Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 31, 2023Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 15, 2023RBC CapitalReiteratedOutperformOutperform
May 4, 2023RBC CapitalMaintained—Outperform
Jan 6, 2023Morgan StanleyMaintained—Equal-Weight
Nov 11, 2022RBC CapitalInitiated—Outperform
Nov 10, 2022Morgan StanleyMaintained—Equal-Weight
Nov 9, 2022Goldman SachsMaintained—Buy
Oct 11, 2022Morgan StanleyMaintained—Equal-Weight
Aug 3, 2022Goldman SachsMaintained—Buy
Aug 2, 2022Morgan StanleyMaintained—Equal-Weight
Jul 18, 2022StifelMaintained—Buy
Jul 14, 2022Morgan StanleyDowngradeOverweightEqual-Weight
Jun 14, 2022Cowen & Co.Maintained—Outperform
Jun 14, 2022StifelMaintained—Buy
May 5, 2022Morgan StanleyMaintained—Overweight
May 5, 2022SVB LeerinkMaintained—Outperform